Homozygosity lor a 677C-+T mutation at the locus that codes for 5,10-methylenetetrahydrofolate reductase (MTHFR), a folate-dependent crucial enzyme in homocysteine metabolism, may render the enzyme thermolabile and less active and has been associated with increased levels of plasma total homocysteine (tHcy). We assessed whether this mutation was associated with increased risk of coronary atherosclerosis and plasma levels of tHcy and furthermore studied whether folate status would modify the associations. Data were collected from subjects with substantial coronary atherosclerosis (;>90% occlusion in one and £: 40% occlusion in a second coronary artery, referred to as cases, it = 131) or virtually no coronary narrowing (referred to as coronary controls, n = 87) and from a population-based control group (n ~ 100), all residing in the Rotterdam area. The Netherlands. Both males and females, aged 25-65 years were studied. The frequency of homozygosity for the mutation ( + / + ) in cases (10.0%) di not significantly differ statistically from that observed in coronary controls (11.5%, P = 0.71), population-based controls (7.0%, /? = 0.43), or combined control groups (9.1%, P « 0.80). In the overall group (as well as in the three subgroups), plasma tf-Icy levels, fasting and to a lesser extent after a methionine-loading test, were higher in + / + subjects than in homozygous normal / -), whereas heterozygous subjects ( + / -) had intermediate levels (P trend 'V B 0.001). The + / + erythrocyte folate levels <790 nmol/1 (population median) had a 77% (95% Cl, 27-144%) higher geometric mean fasting tHcy (21.4, /¿mol/1) than those with higher erythrocyte folate (12. j /¿mol/1). The odds ratio (OR) of coronary atherosclerosis for + / + subjects, with + / and I subjects as the reference group, in analyses with combined control groups, was 1.1 (95% Cl, 0.5 -2.4). The ORs were 2.2 (95% Cl, 0.7 6.8) and 0.6 (95% Cl, 0.2 1.7) among subjects with low and high folate levels, respectively. Our study indicates that homozygosity lor the 677C -*■ T MTHFR mutation, especially in combination with low folate status, predisposes to high plasma levels of fasting tHcy. However, homozygosity for this mutation, whether or mil in combination with low folate status, was not associated with increased risk of coronary artery disease. (O 1997 Elsevier Science Ireland Ltd.
Introduction * Corresponding author.
Elevated plasma total homocysteine (tHcy), an inde pendent risk factor for atherosclerotic vascular disease [1, 2] , is partly genetically determined [3, 4] . Homocys-teine is formed from methionine and is either catabolized in the vitamin B<,-dependent transsulfuration path way or remethylated to methionine. This latter reaction is catalyzed by the enzyme methionine synthase, which requires 5-methyltetrahydrofolate (5-methyl-THF) as substrate and vitamin B12 as cofactor. 5-Methyl-THF is formed by the reduction of 5,10-methylene-THF by 5,10-methylene-THF reductase (MTHFR), which is a regulating enzyme in homocysteine metabolism [5] . Consequently, deficiencies of MTHFR may result in elevation of plasma tHcy. severe coronary occlusions (referred to as cases) or without substantial coronary occlusions (referred to as coronary were included. control group was drawn from the general population and comprised subjects with no history of cardiovascular disease (referred to as population-based controls). Ex clusion criteria for all groups were diabetic, renal, hepatic, thyroid or gastro-intestinal disease, cancer, al cohol or drug abuse and psychiatric illness.
At angiography, projections were made of the major coronary vessels using standard catheterization tech-In 1988, Kang et al. [6, 7] discovered a variant of the niques. A team of cardiologists reviewed the projections MTHFR enzyme, characterized by a specific enzyme activity of approximately 50% of the normal activity. The enzyme appeared to be thermolabile, providing an opportunity to distinguish between this variant and the normal enzyme. Furthermore, and others de scribed that thermolability of MTHFR was common in the normal population (5%), associated with raised tHcy levels, and increased risk of coronary artery dis ease [8] [9] [10] . Recently, a 677C-+T mutation was de tected in the MTHFR gene, and homozygosity for this mutation was associated with decreased specific enzyme activity, increased thermolability, and elevated tHcy [11] , mainly in subjects with low levels of plasma folate [12, 13] . Several investigations have now studied whether homozygosity for the MTHFR 677C->-T mu tation is a risk factor for cardiovascular disease. Three studies found a two-to threefold increased risk for atherosclerotic vascular disease [14] [15] [16] , one study found a twofold increased risk for thrombotic vascular disease [17] , but seven other studies observed virtually no association or even a slight inverse association be tween homozygosity for the mutation and risk of car diovascular disease [18, 24] .
In the present study, we investigated the frequency of 677C-+T genotype and its association with tHcy levels before and after methionine loading in subjects with severely occluded coronaries and normal coronaries, and in controls from the general population. Since an adequate folate status may counterbalance the defective production of 5-methyl-THF in subjects with thermo labile MTHFR, we also studied the interactive effect of genotype and erythrocyte folate status on plasma tHcy level and on risk of coronary atherosclerosis.
Patients and methods

i . I. Study population
A case-control study was conducted from June 1992 to June 1994. Cases and one control group were se lected from patients aged 25-65 years, who underwent coronary angiography in the Zuiderziekenhuis Hospital and prepared angiography reports. Based on these, a trained research nurse selected potential cases and coro nary controls. Cases were defined as those having > 90% occlusion in one and > 40% occlusion in one additional coronary artery. Notably, 77.1% of the cases had > 70%) occlusion in a second vessel. Coronary controls were defined as those having < 50% occlusion in only one coronary artery. The majority (79.5%), had no substantial coronary narrowing in all three arteries, whereas only 5.7% of them had 50%) stenosis in a single coronary vessel. Thus, there was a marked contrast between cases and coronary controls, reducing the pos sibility of disease misclassification.
The conditions that led to angiography were mainly angina pectoris, whereas in some coronary controls a known valve defect was the reason. A total of 67 (51.1%) cases and six (6.9%) coronary controls had a history of myocardial infarction prior to angiography. In the coronary controls, the myocardial infarctions were due to coronary spasms or other nonatherosclerotic causes.
During the period, a total of 2659 patients underwent coronary angiography. Of these, 2292 were not included because of over 65 years ( n 1122), coronary occlusion outside ranges of case in the Netherlands. Subjects with and control definition (n = 486), or the presence of one or more other exclusion criteria. Of the 367 subjects that were invited, 353 (96.2%) could be reached and of 222 were willing to participate (131 cases, 91 coronary controls, response rate of 62.9%). Three of the 91 coronary controls that had originally participated, were excluded from analysis, as their angiography re ports mentioned too much coronary narrowing at sec ond evaluation (but not enough to be included in the study as a case). Furthermore, genotyping was not performed for one coronary control subject, leaving 87 coronary controls for analyses.
We obtained a population-based control group, from a register of about 10 000 men previously, randomly, sampled from the catchment area of cases for participa tion in a cholesterol-lowering trial (which was not conducted). Among men with no prior history of car diovascular disease or diabetes, a random sample of 152 were invited for participation. Fifteen could not be reached, 14 did not meet the inclusion criteria and 47 were not interested, leaving 76 study subjects for partic ipation (response rate of 61.8%). One participant was excluded from analysis because he reported diabetes at the interview. Spouses of 45, randomly chosen, male participants were invited to participate, of whom 12 were not eligible, seven were not willing to participate, leaving 26 women for participation (response rate of 78.8%). Thus, a total of 101 population-based control was was not populationbased controls for analyses. All participants gave their written informed consent. The study protocol was ap proved by the medical ethics committee.
Blood sampling and examination
At the day of the examinations, venous blood sam ples were obtained from all subjects between 08:30 and 09:30 h, after a 10 -12 h fast. L-methionine (0.1 body weight) mixed with orange juice was given orally, together with a standardized low protein breakfast. After breakfast, subjects were interviewed about medi cation, smoking habits, alcohol consumption and other coronary risk factors. Subjects received a standardized low protein lunch and were asked not to consume any protein containing foods, like milk, cheese or meat. At 6 h after methionine administration, a second sample was drawn for estimation of plasma tHcy in response to methionine provocation. From one popula tion-based control subject, we did sample after methionine loading. pressure re* were 11 *e methionine loading test seated after 5 min rest. Height and shoes and heavy clothing) were measured in the morn ing.
For measurement of whole blood folate, 200 /d of EDTA blood was mixed with 4 ml (1:20) freshly pre-1% (w/v) ascorbic acid solution. The rest of the EDTA blood, to be used for measurement of tHcy and creatinine in plasma, was placed on ice immediately and in the dark, and centrifuged at 4°C within I h. Serum was obtained for measurement of total and I $ I
Biochemical analyses and freno typing
Plasma tFIcy, 'fers to sum of proteinbound, free oxidized and reduced species of homocys teine in plasma, was determined by a modification of the method of Refsum et al. [25) . Folate in whole blood by radio immunoassay Products Corporation, Dual-count solid phase assay) by Mimelab-Ab, Soraker, Sweden. We expressed folate concentration per haematoerit, referred to as erythrocyte folate. Folate values were missing in two cases and two coronary controls. Creatinine, total and HDL cholesterol (after precipitation of LDL and VLDL) were determined with enzymatic pho tometry.
DNA was obtained from the buffy coat of EDTA blood [26] The mutation involves a C to T mutation at nucleotide 677, which converts an alanine to a valine residue. The alteration creates a used for mutation analysis. The method has scribed in detail elsewhere [11] . We used the ; 4 was f a n H * •»♦•TO* / to refer to s homozygous for the mut mutation, i lively. Current smoking was tobacco at the time of a day of methionine loading (controls), defined as hypertensive with a systolic blood pressure > 160 mmHg or diastolic blood pressure > 95 111111 Hg, or when they were using anti-hypertensive medication. Hypercholesterolemia was defined as serum cholesterol > 6.5 mmol/1 or the use of cholesterol-lowering drugs.
Differences in age, gender, and various other cardio vascular risk factor levels (adjusted for age and gender) between cases and each of the two control groups wen tested for significance with Student's /-test for ous variables and Pearson s X2 test for frequency mea-
To study frequency s, we use cases *'iwAn't' ",2 test. Furthermore s 7 >) and 95% confidence intervals (CIs) for + / + j and / " s enee group. We performed these analyses groups and all controls combined
We compared in the overall study population and in mips of jases i ei s lor tre I* * * t ested with Student's t-test, formed with linear regression analysis. Calculation of ORs and of were repe by strata of ei folate levels. We level (790 nmol/1) of the -point for the folate strata. This cutoff-point would leave us w ble statistical power in too small to i s more met v ii. P ~v 1 1 is are for two-tailed tests. 
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Results
Characteristics and tHcy
MTHFR genotype
Age, gender, coronary risk factors and plasma tHcy levels of the cases and the two control groups are shown in Table 1 . Except for age and gender, all other risk factors were adjusted for age and gender. In com parison with each of the control groups, cases had a statistically significant higher mean age, proportion of hypertensive subjects, mean level of total/HDL choles terol, mean serum level of triglycerides and mean pack years of smoking. In addition, cases had a statistically significant higher proportion of males and mean diastolic blood pressure, compared to coronary controls. Furthermore, compared to population-based controls, cases has a statistically significant higher proportion of hypercholesterolemic subjects and a lower mean alcohol consumption. The mean plasma level of creatinine was slightly (but not statistically significant) higher in cases (data not shown).
Geometric means of age-and sex-adjusted plasma levels of tHcy were higher in cases than in any of the two control groups (Table 1 ). However, the difference was statistically significant only for post-load tHcy in the comparison with coronary controls. To increase statistical power, we combined both control groups. Cases had 9% higher geometric mean fasting tHcy levels (P = 0.02) and 7% higher geometric mean post load tHcy levels (P = 0.04) than the combined control groups, after adjusting for age and gender. The geomet ric mean of increase after loading (i.e. post-load minus fasting level), was 6% (P = 0.15) higher in cases relative to the combined control groups.
In the total study population, the allele frequency of the mutation was 33%. The frequency of homozygosity for the mutation ( + / + ) in cases (10.0%) did not statistically differ significantly from that observed in coronary controls (11.5%, P -0.71), population-based controls (7.0%, P = 0.43) or combined control groups (9.1%, P = 0.80) ( Table 2) .
Gender ratio, age, serum creatinine and risk factors for coronary artery disease (body mass index, alcohol consumption, serum levels of total/HDL cholesterol, triglycerides, hypertension and pack years of smoking) were not materially nor significantly different statisti cally between the genotype subgroups, in any of the three study groups, nor in the total study population.
Levels of tHcy by M TH FR genotype
Geometric mean levels of tHcy were highest among the + 1 + subjects and lowest among the / subjects. The + / -individuals had slightly elevated levels, compared to / subjects (Table 3 ). This was true for all three measurements of tHcy, both in cases and each of the control groups, with the exception of tHcy increase after methionine loading in population-based mean was slightly higher in + / -subjects than in + / + subjects, although both groups had higher geometric mean levels than I subjects. Ratios of geometric mean tHcy levels of + / + subjects to levels of I subjects were highest for fasting tHcy and lowest for the increase in tHcy after methionine loading; when In the combined study groups, tests for iar trend were statistically three tHcy measurements. pack years of smoking) for -f/+ genotype was 1.2 (95% Cl, 0.5 3.2).
Effect modification by erythrocyte folate
MTHFR ge atherosclerosis and risk o f coronar]
Since elevation of tHcy was much more obvious for -1-1 + subjects than + / -subjects, in accordance with and other publications [11, 16, 21] , we considered _1_ i subjects as one reference group (i.e. OR 1.0). The ORs for + / -I-genotype were 0.9 (95% Cl, 0.4 2.0) and 1.5 (95% Cl, 0.6-3.8), with coronary controls and population-based controls as referents, respectively. When performing analyses with combined control groups, the OR for + / + genotype was 1.1 (95% Cl, 0.5-2.3). The corresponding multivariate adjusted OR (i.e. adjusted for age, gender, body mass index, alcohol serum of total/HDL serum creatinine and Erythrocyte folate did not materially nor statistically significantly differ between the genotypes, neither in the separate study groups, nor in the pooled study groups (data not shown). Using combined data of the entire study population, we calculated plasma tHcy levels of groups with low and high erythrocyte folate, per geno type, as shown in Fig. 1 . Geometric mean plasma tHcy was higher for the subjects with low compared to those with high erythrocyte folate, especially in the + / + group. As Fig. 1 is merely a demonstration, Table 4 shows mean levels of tHcy for individuals with low and high folate status in the ■ + • / + group. The relation was most evident for fasting tHcy, as shown in Fig. 1 and Table 4 .
High folate
Low folate Table 3 Geometric mean plasma total homocysteine by MTIIFR genotypes -1 8 -4 2 % ) i m é t t i Finally, using combined control groups, we calcu lated ORs of coronary atherosclerosis for + / + subjects relative to -f / and / subjects, for strata of low and high erythrocyte folate level. The ORs were 2.2 (95% Cl, 0.7-6.8) and 0.6 (95% Cl, 0.2-1.7) among subjects with low and high folate levels, respectively. However, the interaction was not statistically signifi cant; the P-value for the interaction term of folate homocysteine remethylation, whereas increased post load tHcy primarily reflects abnormalities in the transsulfuration pathway [28, 29] . The only other study [12] that also studied the relationship of the mutation with increase in tHcy after methionine loading (i.e. after subtracting fasting level, which in fact is a better reflec tion of transsulfuration than absolute post-load tHcy level), observed no differences between the genotypes. status and + / + genotype was 0.11 and the logistic regression model including genotype, folate status and the interaction term did not significantly increase the log likelihood ratio estimate in comparison to a model including only genotype and folate status. The ORs
In contrast with their finding, we observed a statisti cally significant 18% higher geometric mean of increase in tHcy after methionine loading in + / 4-subjects compared to / subjects (Table 3) . Whether this is a chance finding or whether this indicates an effect of were not materially affected by multivariate adjustment the mutation on homocysteine transsulfuration needs to for age, gender and other major coronary risk factors, but CIs widened substantially.
Discussion
In the present investigation, we showed that ho mozygosity for the 677C -> T mutation in the M THFR be determined in future studies.
Other studies have observed that the trend of higher tHcy levels among + / + subjects was only apparent in those with low folate levels in plasma or serum [12, 13, 21] . However, those findings might still have been due to an artefact, as + / + genotype is associ ated with reduced plasma folate concentration (the main circulating form of folate in plasma is 5-methyl-THF) [13, 20, 21, 27] . As there is still some variation in activity within the group of + / -I-subjects MTHFR gene was associated with raised plasma tHcy levels, particularly when measured in the fasting state. How ever, + / + genotype was not associated with increased [11, 16] , it is not unlikely that 4-/ + subjects at the low risk o f severe coronary atherosclerosis. Elevation of end of the range of enzyme activity will have both low tHcy in + / + subjects was limited to those with erythrocyte folate levels below the median of the study population. However, we have not been able to prove the hypothesis that the combination of + / + genotype and low folate status infers an increased risk of coro nary artery disease.
Our observation of elevation of tHcy levels in + / + subjects compared to / concentrations of plasma folate and high concentra tions of tHcy (and those at the high end of enzyme activity will vice versa have both high folate and low tHcy). We observed no difference in erythrocyte folate levels among the various genotypes, but we found a dose-response relation between 677C ->■ T genotype and plasma tHcy. Furthermore, we observed higher fasting and + / -subjects is tHcy levels among subjects with low compared to high cellular folate status M THFR supported by other studies [11] [12] [13] [14] 16, 21, 27] . In our erythrocyte folate, which is in agreement with results study, as well as in others that studied the relation of published by others [30] . Thus, our data suggest that the mutation with both fasting and post-load tHcy levels [11, 14, 16] , the trend was stronger for fasting than for post-load levels. These findings support the idea that fasting tHcy level is to a large extent determined by independent as well as interactive relations with plasma tHcy. Erythrocyte folate is a measure of tissue folate A stores, which reflects the balance between folate intake,
P. Verhoef et al. / Atherosclerosis 132 (1997) 105 113
III absorption, metabolism, and utilization [31] . Provided that the determinants of folate homeostasis other than folate intake are similar within groups of genotype, our findings suggest that adequate intake is essential for maintaining low tHcy in 4-/ 4-subjects. Furthermore, our finding of higher post-load increase tHcy levels in 4-/ + subjects possibly shows that these individuals may also benefit from increasing intake of vitamin Bf), the coenzyme in the transsulfuration pathway.
Surprisingly, subjects with the 4-/4-genotype did not have increased risk of coronary atherosclerosis, despite elevated levels of tHcy, which is generally con sidered to be an independent risk factor for cardiovas cular disease [1] . When including only coronary controls in the risk analyses, we observed an OR of 0.9 for 4-/4-genotype, compared to the / _l-/ genotypes. With population-based controls, we estian OR of 1.5, but neither of the ORs was statistically significant nor did the ORs differ statisti cally significantly from each other. There was a fair contrast between cases and coronary controls with re spect to coronary artery narrowing, but in the coronary controls we had no information on the occurrence of thrombi leading to angina without coronary artery narrowing. Assuming that these were common and related to M THFR genotype, this may have attenuated the association to some extent. In population-based controls, on the other hand, one is never sure about the extent of coronary artery narrowing, since these con trols may have substantial, although not clinically man ifest coronary atherosclerosis. This again may have lead to some attenuation of the association. However, the type of design we used, i.e. selecting cases and controls by extent of coronary narrowing, and additionally studying an unselected populationbased control group, has been applied by others and both those studies and ours have shown positive, independent associations be tween plasma tHcy and risk of coronary atherosclerotic disease [32.34] .
Other epidemiologic studies that estimated risk of v / I t* conflicting results. Kluijtmans et al. [16] , the first ones to report on the association, found an OR of vascular disease of 3.1 (95% Cl, 1.0 9.2) for 4-/4-genotype in I comparison with + / -; discrepancy between our present study and their study, both conducted in Dutch populations, may be ex plained by the fact that they selected young patients, with absence of hyperlipoproteinemia, hypertension and diabetes mellitus, i.e. individuals that were other wise at a low risk of cardiovascular disease. A Japanese [15] , found a statistically significantly, twofold increased risk of myocardial infarction for 4-/ + geno type. An Irish study [14] , showed a statistically signifi cantly threefold increased risk of premature coronary artery disease. From data of a study conducted in Italy [17] , we derived an OR of 2.4 (95% Cl, 1.3 4.6) lor early onset venous or arterial occlusive disease or thrombosis occurring at unusual sites. Adams et al. [18] , in a study of myocardial infarction conducted in the UK, found an OR of 0.9 (95% Cl, 0.5 1.5). An Australian study by Wilcken et al. [24] ar to ours, comparing p; without angiographically documented coronary artery disease and healthy subjects. They m OR of 1.0 (95% Cl, 0.6..1.7) for the comparison of subjects w ■'»ase with those with no or were similar when coronary w severe coronary disease were compared to healthy sub jects. A study conducted in the Boston area [23] found an OR of myocardial infarction of 1.1 (95% Cl, 0.6 1.9). Ma et al. [21] compared to others. The majority of studies found an estimate much than (is included the value of 1.5, and be totally ruled out as a factor that exerts increased risk of cardiovascular disease through tHcy elevation. How ever, based on the currently available data, it is certainly not an important risk factor for cardiovaseulat * '/vi en It is not unlikely, however, that the 4 / 4 will only as a sease in a s factor for cardiovascular ation with a low folate status. This may explain why positive associations were < served in populations where use of vitamin supplements # i is and fortification of uncommon (i.e. Dutch [16] or Irish population [14] ), as to no assocr in * [20, 21, 23] , where use of sumption of folate md con cerei is more common studies that investigi 112 P. Verhoef et ul. / Atherosclerosis 132 (1997) W ß 1 1 3 tion of the mutation with risk of cardiovascular disease among subgroups of low and high folate intake [23] , or References plasma folate [21] did not show a significantly positive relationship among those with low intake or plasma levels of folate either. With our data we were not able to prove the hypothesis that + / 4-genotype is a risk factor for coronary atherosclerotic disease among those with low erythrocyte folate levels either.
The absence of a positive association between + / -f genotype and risk of coronary heart disease may thus indicate that elevated plasma tHcy is not a risk factor for cardiovascular disease, but merely a marker of low folate status, which for example through prothrombotic action confers the actual risk, as recently suggested by results from an animal study [35] . Another explanation could be that the mutation has a protective effect, that mitigates against the adverse effect of elevated plasma tHcy. This aspect may need further study.
In conclusion, we have demonstrated a positive inter action between the 677C-+T + / + genotype and low erythrocyte folate, resulting in elevated plasma tHcy, especially in the fasting state. However, subjects who are homozygous for this common mutation, whether or not with a low folate status, did not have increased risk of coronary atherosclerosis. This absence of an associa tion between the mutation and risk of cardiovascular disease, also observed in many other studies, either indicates that elevation of plasma tHcy is not a risk factor for cardiovascular disease, or that the mutation I ?
has a beneficial effect as well, which mitigates against the potential harmful effects of tHcy elevation. The here suggest that increased dietary results folate intake is a means to lower plasma tHcy levels in subjects who are homozygous for the M THFR muta tion, but subsequent effects on risk of coronary heart disease are uncertain.
